Close

Biota Pharma (BOTA) Becomes Aviragen Therapeutics; Will Trade Under 'AVIR'

April 12, 2016 7:06 AM EDT Send to a Friend
Biota Pharmaceuticals, Inc. (Nasdaq: BOTA) announced that the Company has changed its name to Aviragen Therapeutics, Inc., (“Aviragen Therapeutics”), a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login